Intrinsiqq
Atea Pharmaceuticals Inc. logo

Atea Pharmaceuticals Inc. Insider Trading

AVIR

Compare
Last 12 months

Insiders bought 25K and sold 320K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Bruce Polsky sold 168K on Nov 18, 21% of their stake, outside a plan.

Net open-market
−294K
1 buy · 3 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
1 / 2
executives and directors
Last open-market buy
May 2026
May 18, 2026

Get an email when AVIR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 17 – 19No plan
    Bruno Lucidi
    Director · sold 29,360 at avg $3.96
    116K
    14% of stake
  • Nov 19No plan
    Bruce Polsky
    Director · sold 8,750 at $4.03
    35K
    5.5% of stake
  • Nov 16 – 18No plan
    Bruce Polsky
    Director · sold 41,226 at avg $4.08
    168K
    21% of stake
  • May 18
    Polly A. Murphy
    Director · bought 6,100 at $4.17
    25K
    7.1% of stake
  • May 18, 2025
    Polly A. Murphy
    Director · bought 6,100 at $4.17
    25K
    7.1% of stake
  • Jan 15, 2025 – Jan 16, 2025
    Franklin M Berger
    Director · bought 25,000 at avg $3.26
    81K
    5.0% of stake
  • Jan 15, 2025 – Jan 16, 2025
    Franklin M Berger
    Director · bought 25,000 at avg $3.26
    81K
    5.5% of stake
  • Dec 10, 2024No plan
    Franklin M Berger
    Director · sold 359,606 at $2.85
    $1.02M
    44% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AVIR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with AVIR

CompareIntrinsic value
XERSXeris Biopharma Holdings, Inc.
$16.97+2.11%34
EOLSEvolus Inc.
$6.52-6.86%30
AUPHAurinia Pharmaceuticals Inc.
$14.70-1.28%58
IRWDIronwood Pharmaceuticals Inc.
$4.70-0.21%63
MNKDMannKind Corporation
$3.85-2.53%30
HROWHarrow Inc.
$30.41-5.35%15
SNDXSyndax Pharmaceuticals Inc.
$8.72-4.49%0
ESPREsperion Therapeutics Inc.
No recent price50

Held by ETFs

AVIR is in 13 US ETFs. The largest of them, with AVIR's weight in each:

Spot a number that looks wrong? Check it in AVIR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing AVIR

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.